title: Intrapleural rituximab for the treatment of malignant pleural effusion due to B-cell lymphomas.
authors: Man Fai
authors: MF
authors: Law
authors: Sze Fai
authors: SF
authors: Yip
authors: Wai Lun
authors: WL
authors: Poon
authors: Hay Nun
authors: HN
authors: Chan
authors: Ho Kei
authors: HK
authors: Lai
authors: Chun Yin
authors: CY
authors: Ha
authors: Celia S S
authors: CS
authors: Ng
authors: Yiu Ming
authors: YM
authors: Yeung
mesh_terms: D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004333:Drug Administration Routes; D006801:Humans; D016393:Lymphoma, B-Cell / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D016066:Pleural Effusion, Malignant / Q000188:drug therapy* / Q000209:etiology; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab